Skip to main content
. 2023 May 18;16:1193590. doi: 10.3389/fnmol.2023.1193590

Table 1.

Summary of the tested dosages and effects of purified phlorotannins and phlorotannin-rich extracts in published in vivo rodent studies.

Category Substance Min. effective dose Timing Route Animal model Stimulus Outcome Reference
Memory Dieckol 1 mg/kg Once daily for 7 days Oral ICR mice Ethanol 3 g/kg (38% v/v solution in water) - acute alcohol intoxication Prevention of memory loss during retention phase (passive avoidance test) Myung et al. (2005)
Memory PFF-A 0.2 mg/kg Once daily for 7 days Oral ICR mice Ethanol 3 g/kg (38% v/v solution in water) - acute alcohol intoxication Prevention of memory loss during retention phase (passive avoidance test) Myung et al. (2005)
Learning, memory NX42 (20.1% phlorotannin) 100 mg/kg Once daily for 4 weeks Oral ICR mice Electric shocks, 15 times daily for 7 days during learning phase Improved performance during learning and retention phases (water maze test) Lee and Stein (2004)
AD Phloroglucinol 1.2 μmol Once Bilateral stereotaxic injection into hippocampus 5XFAD mice - Rescued spontaneous alternation behavior in spontaneous alteration T-maze test at 12–13 days post-injection. Faster spatial learning in Morris water maze test at 7 days post-injection. Yang et al. (2015)
AD Phloroglucinol 100 mg/kg per day Freely administered in drinking water for 2 months Oral 5XFAD mice - Recovered spontaneous alternation ratio in spontaneous alternation T-maze and Y-maze; reductions in Aβ plaques and BACE1 protein, lipid peroxidation, Iba-1, and GFAP levels; rescued density of stubby and mushroom spines in the hippocampus CA1 subfield Yang et al. (2018)
PD Phloroglucinol 6 μmol Once Stereotaxic injection with 6-OHDA SD rats 6-OHDA via unilateral injection Preserved motor performance in the rotarod test; preserved number of TH+ cells in the SNpc; preserved TH and synaptophysin protein levels in the midbrain; suppressed apomorphine-induced rotation behavior Ryu et al. (2013)
Movement Dieckol 5 mg/kg Once immediately before test Oral Swiss albino mice - Decreased locomotion (open field test) Li et al. (2021)
Stroke Polyphenol-rich extract of Ecklonia cava (98.5% PGE) 10 mg/kg Half of final dose injected 30 min before and after surgery I.p. injection SD rats Middle cerebral artery occlusion-induced transient focal ischemia Reduced apoptosis at 10 mg/kg; reduced infarct size and brain water content at 50 mg/kg Kim et al. (2012)
Seizure Enzymatic extract of E. cava (98.4 mg/g PGE) 1,000 mg/kg 45 min before picrotoxin administration Oral SD rats Picrotoxin (7 mg/kg)-induced clonic seizure Increased latency to seizure onset Cho et al. (2012)
Sleep Dieckol 100 mg/kg 24 h after baseline recording in a 48-h study Oral C57BL/6 N mice - Reduced sleep latency and increased time spent in NREMS at 100 mg/kg; increased frequency of transitions from wake to NREMS at 150 mg/kg Yoon et al. (2020)
Sleep Ethanol extract of E. cava 250 mg/kg 12 h after baseline recording in a 24-h study Oral C57BL/6 N mice - Reduced sleep latency and increased sleep duration at 250 mg/kg; decreased time spent awake and increased time spent in NREMS at 500 mg/kg Yoon et al. (2014)
Sleep Ethanol extract of E. cava Kjellman (138.5 mg/g PGE) 1,000 mg/kg 45 min before pentobarbital administration Oral ICR mice Pentobarbital (30 mg/kg [sub-hypnotic dose] and 45 mg/kg [hypnotic dose])-induced sedation Reduced sleep latency and increased sleep duration Cho et al. (2012)
Sleep Polyphenol-rich extract of E. cava (630.2 mg/g PGE) 50 mg/kg 45 min before pentobarbital administration Oral SD rats Pentobarbital (30 mg/kg [sub-hypnotic dose] and 45 mg/kg [hypnotic dose])-induced sedation Reduced sleep latency and increased sleep duration Cho et al. (2012)
Pain Dieckol 5 mg/kg 30–60 min before pain stimulus Oral Swiss albino mice - Increased reaction latency to hot plate at 5 mg/kg (when supplemented with morphine); increased reaction latency to tail immersion at 10 mg/kg Li et al. (2021)

The minimum effective dose indicates the lowest dosage (mg/kg) of the tested substance that elicited a significant change in a parameter (p < 0.05). mg/g PGE indicates the total polyphenol content in phloroglucinol equivalents. AD, Alzheimer’s disease; PD, Parkinson’s disease; Aβ, amyloid beta; PFF-A, phlorofucofuroeckol A; PGE, phloroglucinol equivalents; i.p., intraperitoneal; NREMS, non-rapid eye movement sleep; SD, Sprague Dawley; GFAP, glial fibrillary acidic protein; SNpc, substantia nigra pars compacta; TH, tyrosine hydroxylase.